Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FACTORFIVE is a biotechnology company specializing in regenerative aesthetics and advanced skincare. The company utilizes ethically sourced human adipose-derived stem cells to produce a proprietary blend of growth factors, cytokines, and copper peptides. Their Human Stem Cell Factor (HSCF) technology is designed to mimic natural cellular signaling to promote collagen synthesis and reduce skin inflammation. FACTORFIVE's products are primarily used in professional clinical settings and by consumers to address signs of aging, sun damage, and post-procedure recovery. By integrating stem cell science with topical applications, the company aims to provide high-efficacy solutions for skin rejuvenation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FACTORFIVE.